---
title: "LYEL.US (LYEL.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LYEL.US/news.md"
symbol: "LYEL.US"
name: "LYEL.US"
parent: "https://longbridge.com/en/quote/LYEL.US.md"
datetime: "2026-05-21T10:03:32.328Z"
locales:
  - [en](https://longbridge.com/en/quote/LYEL.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LYEL.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LYEL.US/news.md)
---

# LYEL.US (LYEL.US) — Related News

### [Lyell Gains Buy Rating on Leadership in CD19/20 CAR-T and Ronde-cel Progress; Analyst Reiterates $45 Price Target](https://longbridge.com/en/news/285536200.md)
*2026-05-07T11:05:34.000Z*
> Mitchell Kapoor from H.C. Wainwright has reiterated a Buy rating on Lyell Immunopharma with a price target of $45. The r

### [Lyell Immunopharma | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 2 K](https://longbridge.com/en/news/285477237.md)
*2026-05-07T03:13:18.000Z*
### [Lyell Immunopharma | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 2 K](https://longbridge.com/en/news/285432579.md)
*2026-05-06T20:26:04.000Z*
### [Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026](https://longbridge.com/en/news/285432388.md)
*2026-05-06T20:07:08.000Z*
> In South San Francisco on May 6, 2026, Lyell Immunopharma, Inc. (Nasdaq: LYEL) shared their financial updates for the fi

### [Lyell Immunopharma (LYEL) to Release Quarterly Earnings on Tuesday](https://longbridge.com/en/news/285244886.md)
*2026-05-05T17:32:17.000Z*
> Lyell Immunopharma (NASDAQ:LYEL) is set to release its Q1 2026 earnings on May 12, with analysts predicting a loss of $2

### [Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Robert W. Baird to Strong-Buy Rating](https://longbridge.com/en/news/284964657.md)
*2026-05-02T11:16:49.000Z*
> Robert W. Baird upgraded Lyell Immunopharma (NASDAQ:LYEL) to a "strong-buy" rating. The company has seen mixed ratings f

### [Bank of America Securities Reaffirms Their Sell Rating on Lyell Immunopharma (LYEL)](https://longbridge.com/en/news/284887872.md)
*2026-05-01T10:47:14.000Z*
> Bank of America Securities analyst Jason Zemansky has reaffirmed a Sell rating on Lyell Immunopharma (LYEL) with a price